Timber Pharmaceuticals, Inc.

AMEX:TMBR

1.4609 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22019 Q42019 Q32019 Q22019 Q12018 Q32018 Q22018 Q12017 Q32017 Q22017 Q12016 Q32016 Q22016 Q12015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q32013 Q22013 Q12012 Q42012 Q22012 Q12011 Q42011 Q22011 Q12010 Q4
Revenue 000.08300000.0420.2540000-0.0370000.010.0240.0180.0180.0170.0190.0330.0190.0330.020.0050.0040000000000000.0010
Cost of Revenue 2.4712.3662.1011.7910000000000.01800000.0130.0070.0080.0090.0110.0280.0170.020.01900.00900000000000000
Gross Profit -2.471-2.366-2.018-1.7910000.0420.2540000-0.0550000.010.0110.0110.010.0080.0080.0050.0020.0130.0010.005-0.0050000000000000.0010
Gross Profit Ratio 00-24.25900001100001.48600010.4580.6110.5560.4710.4210.1520.1050.3940.051-1.2500000000000111
Reseach & Development Expenses 2.4712.3662.1011.7917.8921.5191.5261.9741.80.850.4930.68512.908-2.7770.741.3752.1992.2282.732.3272.1112.4132.9412.4872.9732.1731.6491.1411.0761.8510.8070.6570.3870000000000
General & Administrative Expenses 1.370000000000001.7541.2411.1161.1771.6241.1820.8451.0881.280.5061.1541.1690.0860.931.118-0.0551.5870.5150.8020.270.0460.0020.0020.0030.0020.0050.0010.0020.0030.004
Selling & Marketing Expenses 0000000000000-0.9480.1390.1690.2640.550.5660.6010.5460.5860.7970.5290.8951.1071.271.3071.081-1.3370.7570.3670.2130000000000
SG&A 1.371.6351.4651.3371.5121.7021.4691.2971.5561.0651.3141.2341.0550.8061.381.2851.4412.1741.7481.4461.6341.8661.3031.6832.0641.1932.22.4251.0262.9241.2721.1690.4830.0460.0020.0020.0030.0020.0050.0010.0020.0030.004
Other Expenses 0.15700.083040.0750000000-1.398000.01000.601000.797001.107001.081-0.213000.2130000000000
Operating Expenses 3.84143.5663.1279.4043.1382.8053.0463.2211.8741.7051.59513.963-1.9712.122.663.644.4024.4784.3743.7454.2795.0414.175.0374.4733.8493.5663.1834.7752.0791.8261.0830.0460.0020.0020.0030.0020.0050.0010.0020.0030.004
Operating Income -3.999-4-3.566-3.127-9.404-3.138-2.805-3.004-2.967-1.874-1.705-1.595-14.2743.75-2.12-2.66-3.64-4.452-4.467-4.4-3.735-4.271-5.396-4.165-5.035-4.459-3.848-3.571-3.6245.058-2.079-1.826-1.153-0.046-0.002-0.002-0.003-0.002-0.005-0.001-0.002-0.002-0.004
Operating Income Ratio 00-42.8750000-71.784-11.6870000-101.351000-445.2-186.125-244.444-207.5-251.235-284-126.212-265-135.121-192.4-714.2-90600000000000-690.333-1.981-533.375
Total Other Income Expenses Net -0.065-0.061-0.049-0.06-0.0920.065-0.019-0.0020.001-02.5534.431-0.972-0.0180.0070.0140.0190.0620.057-0.0370.0210.53-0.3630.2870.0010.001000-3.905000-0.007000000000
Income Before Tax -4.063-4.061-3.615-3.187-9.496-3.073-2.824-3.005-2.966-1.8740.8482.836-15.2463.732-2.113-2.646-3.621-4.39-4.41-4.4-3.714-3.741-5.396-3.878-5.034-4.459-3.8480-3.6241.15300-1.153-0.052000000000
Income Before Tax Ratio 00-43.4640000-71.821-11.6830000-100.865000-439-183.75-244.444-206.333-220.059-284-117.515-264.947-135.121-192.40-90600000000000000
Income Tax Expense 0.0650.1240.008-0.0110.050.129-0.0890000.03802.643-0.003000.002000.002000.001000.0020.0020000000000000000
Net Income -4.063-4.185-3.623-3.176-9.546-3.073-2.793-3.005-2.966-1.8740.812.836-15.2463.735-2.113-2.646-3.623-4.39-4.41-4.402-3.714-3.741-5.397-3.878-5.034-4.461-3.850-3.6241.15300-1.153-0.052000000000
Net Income Ratio 00-43.5550000-71.821-11.6830000-100.946000-439-183.75-244.556-206.333-220.059-284.053-117.515-264.947-135.182-192.50-90600000000000000
EPS -1.32-1.36-1.72-1.52-7.49-2.41-2.58-4.1-4.05-2.671.437.5-67.9320.47-0-0-15.26-22.94-23.05-1.22-0.05-0-3.99-12.41-17.56-8.51-00-15.430.00600-0.006-0.006000000000
EPS Diluted -1.32-1.36-1.72-1.52-7.49-2.41-2.58-4.1-4.05-2.671.437-67.9320.47-0-0-15.26-22.94-23.05-1.220-0-3.99-12.41-17.56-8.51-00-15.430.00600-0.006-0.006000000000
EBITDA -3.739-3.913-3.478-3.044-9.324-2.986-2.805-2.931-2.898-1.818-1.654-1.545-13.6033.727-2.12-2.66-3.635-4.452-4.467-4.384-3.735-4.271-5.384-4.165-5.035-4.436-3.848-3.571-3.6095.057-2.079-1.826-1.152-0.046-0.002-0.002-0.003-0.002-0.005-0.001-0.002-0.002-0.004
EBITDA Ratio 00-41.8090000-70.054-11.4130000-100.73000-445.2-186.125-243.556-207.5-251.235-283.368-126.212-265-134.424-192.4-714.2-902.2500000000000-690.333-1.981-533.375